
Nucleosides and Nucleotides p. 31 - 45 (1996)
Update date:2022-07-29
Topics:
Shiragami, Hiroshi
Amino, Yusuke
Honda, Yutaka
Arai, Masayuki
Tanaka, Yasuhiro
Iwagami, Hisao
Yukawa, Toshihide
Izawa, Kunisuke
Practical method to produce 2′,3′-dideoxypurinenucleosides from 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-β-D-xylofuranosyl)purines (1) was developed. High ratio of 2′,3′-dideoxynucleoside to 3′-deoxyribonucleoside was obtained by selecting the reaction conditions (solvent, pH and/or base), or changing 2′-acyloxy leaving group. The reaction mechanism was studied by deuteration experiments of 1a and 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-ribofuranosyl)thymine (12).
View MoreWeifang Jahwa Chemical Co.,Ltd
Contact:0086-536-8897731,8897730
Address:No.5166 East Dongfeng Street,Weifang,Shandong,China
Tianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Anhui Eapearl Chemical Co., Ltd.
Contact:86-562-5858458
Address:358 South Huaihe Road
Tianjin Jiuri New Materials Co., Ltd.
Contact:+86-22-58889220
Address:C-5/6, Vison Hill, No.1 Gonghua Road, Huayuan Hi-tech Park, Tianjin, China.
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Doi:10.1560/7J4F-D8BG-3FQR-E3TD
(2000)Doi:10.1016/S0960-894X(01)00254-2
(2001)Doi:10.1039/jr9440000338
(1944)Doi:10.1007/BF00477427
()Doi:10.1021/jo00799a032
(1972)Doi:10.1016/S0040-4039(01)00938-8
(2001)